COVID-19 vaccine rollout on hold

Serious questions are being asked over due diligence and cost after the rollout of the Oxford AstraZeneca vaccine was postponed. The vaccine has been found to be less effective against the COVID-19 variant first discovered in South Africa. Many in the medical fraternity are also asking why questions over an April expiry date - just weeks away - weren't raised earlier. eNCA’s Masego Rahlaga is working those angles for us and leads Monday Lunchtime. Courtesy #DStv403